Table 1 Clinical characteristics of the normal control and diabetic patients before and after 3 months of telmisartan treatment
Normal control (n = 10) | Baseline (n = 15) | After telmisartan (n = 15) | p value | |
|---|---|---|---|---|
Age (years) | 52.2 ± 8.5 | 55.3 ± 8.8 | – | 0.25 |
Male (%) | 6 (60) | 11 (73.3) | – | 0.12 |
Body height (cm) | 165.8 ± 7.4 | 163.9 ± 8.7 | – | 0.72 |
Body weight (kg) | 68.6 ± 7.1 | 70.8 ± 10.6 | – | 0.81 |
Heart rate (beats/min) | 69.8 ± 7.6 | 73.5 ± 8.24 | 72.38 ± 11.74 | 0.64 |
Systolic blood pressure (mmHg) | 120.2 ± 12.9 | 129.6 ± 17.1 | 122.1 ± 14.4 | 0.06 |
Diastolic blood pressure (mmHg) | 83 ± 8.9 | 82.6 ± 7.7 | 85.2 ± 13.9 | 0.43 |
Preprandial serum glucose (mg/dL) | 92.7 ± 5.6 | 122 ± 15.8 | 105.3 ± 10.6 | 0.01 |
HbA1c (%) | 5.6 ± 0.9 | 7.8 ± 1.2 | 7.2 ± 0.8 | 0.02 |
Creatinine clearance rate (ml/min) | 108.7 ± 45.8 | 83.7 ± 24.5 | 95.8 ± 24.6 | 0.29 |
Triglyceride (mg/dL) | 122.6 ± 51.3 | 129 ± 6.2 | – | 0.59 |
Cholesterol (mg/dl) | 178.7 ± 28.8 | 178.6 ± 32.3 | – | 0.67 |